Development

Feliza Mirasol is the science editor for 

Articles

New and emerging biotherapeutic molecules drive the need for innovative solutions to meet cold-chain requirements.

Finding Solutions to Cold Chain Supply

Raymond P. Goodrich, PhD, is the founder of PhotonPharma, executive director of the infectious disease research center at Colorado State University, and professor for the department of microbiology, immunology, and pathology at Colorado State University.

Amanda Guth, DVM, PhD, is the chief scientific officer for PhotonPharma.

Jon Weston is the president and CEO of PhotonPharma.

Terry Opgenorth, PhD, is the executive in residence life sciences for CSU Ventures.

Gary Gordon, MD, PhD, is the president of Global Coalition for Adaptive Research.

Autologous tumor cells engineered for immune system stimulation can target unique metabolic, genomic, and phenotypic characteristics of cancer cells.

Formulating Autologous Therapies for Cancer

Crystec and Biosidus have joined forces to enhance the delivery and performance of biotherapeutics.

Crystec, Biosidus Collaborate on Enhanced Delivery and Performance of Biotherapeutics 

EMA's CHMP has approved two new manufacturing sites and a ready-to-use formulation of Comirnaty.

EMA Approves Two New Manufacturing Sites and a New Formulation for Comirnaty

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Next-Gen Technologies Tackle Drug Delivery Challenges

Editor of Pharmaceutical Technology Europe

The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.

Getting a Nose for Vaccines

Moderna announced a collaboration to develop a new mRNA therapeutic for Crigler-Najjar Syndrome Type 1 at no cost to patients.

Moderna and ILCM Announce Collaboration to Develop mRNA Therapeutic for CN-1

Joana S. Cristóvão, PhD, jscristovao@hovione.com, is an analytical scientist at Hovione Farmaciência S.A., R&D, Analytical Development.

Salomé Neto was a Master’s student at Hovione Farmaciência S.A., R&D, Analytical Development.

Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.

Conformational and Colloidal Stability Studies to Predict the Best Biopharmaceutical Formulation

Syngene International appoints two US-based executives to senior level positions.

Syngene Announces Senior Level Appointments

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Advances in technology are accelerating the development and manufacture of subunit vaccines, an established class of vaccines.